Industries > Pharma > Nuclear Medicine Market Report 2020-2030

Nuclear Medicine Market Report 2020-2030

Revenue Prospects by Type (Diagnostic Nuclear Medicine (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters, Brachytherapy Isotopes)), Application (Diagnostic Applications (PET Applications, SPECT Applications), Therapeutic Applications (Bone Metastasis, Endocrine Tumors, Lymphoma, Thyroid, Other Therapeutic Applications)) and Geography

PAGES: 188
PRODUCT CODE: PHA0618
SUBMARKET:

Clear
WOOCS 2.2.1
SKU: PHA0618 Category: Tag:

Nuclear Medicine– our new study reveals trends, R&D progress, and predicted revenues
Where is the Nuclear Medicine market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 150+ page report provides 60 tables, 48 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Nuclear Medicine Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the Nuclear Medicine market, with forecasts for 2 Types, 2 Applications each forecasted at a global and regional level.

Global Nuclear Medicine Market by Type
– Diagnostic Nuclear Medicine
– PET Radiopharmaceuticals
– F-18
– Ru-82
– Other PET Isotopes
– SPECT Radiopharmaceuticals
– Tc-99m
– Tl-201
– Ga-67
– I-123
– Other SPECT Isotopes
– Therapeutic Nuclear Medicine
– Alpha Emitters
– Ra-223
– Beta Emitters
– I-131
– Y-90
– Sm-153
– Re-186
– Lu-177
– Other Beta Emitters
– Brachytherapy Isotopes
– I-125
– Ir-192
– Pd-103
– Cs-131
– Other Brachytherapy Isotopes

Global Nuclear Medicine Market by Application
– Diagnostic Applications
– PET Applications
– Cardiology
– Oncology
– Neurology
– Other Pet Applications
– SPECT Applications
– Cardiology
– Lymphoma
– Neurology
– Thyroid
– Other SPECT Applications
– Therapeutic Applications
– Thyroid
– Bone Metastasis
– Endocrine Tumors
– Lymphoma
– Other Therapeutic Applications

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

– North America:
– U.S.
– Canada

– Latin America:
– Brazil
– Mexico
– Rest of Latin America

– Europe:
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe

– Asia-Pacific:
– Japan
– China
– India
– Australia
– ASEAN
– Rest of Asia-Pacific

– MEA:
– GCC Countries
– South Africa
– Rest of MEA

The report also includes profiles and for some of the leading companies in the Nuclear Medicine market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth
Overall world revenue for Nuclear Medicine Market will surpass $7 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Nuclear Medicine Market report helps you
In summary, our 150+ page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 3 segmentations of the Nuclear Medicine market, with forecasts for 2 Type,s 2 Applications, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

– Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the Nuclear Medicine market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.

– Prospects for established firms and those seeking to enter the market– including company profiles for 16 major companies involved in the Nuclear Medicine market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Nuclear Medicine market and leading companies. You will find data, trends and predictions.
Get our report today The Nuclear Medicine Market Forecast : Revenue Prospects by Type {Diagnostic Nuclear Medicine (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters, Brachytherapy Isotopes)}, Application {Diagnostic Applications (PET Applications, SPECT Applications), Therapeutic Applications (Bone Metastasis, Endocrine Tumors, Lymphoma, Thyroid, Other Therapeutic Applications)}, and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Nuclear Medicine Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Nuclear Medicine Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2021-2031

Increasing demand for medical products in developing as well developed economies coupled with rising ageing population is expected to open new opportunities for medical device contract manufacturing industry over the forecast period.

01 December 2020

READ

Visiongain Publishes Virus Testing Diagnostic Kits Market Report 2021-2031

With the growing burden of rare diseases around the world, there has been a rise in the requirement for proper diagnosis as well as full proof treatment positions for various chronic diseases. With increasing awareness regarding symptoms of various terminal illnesses, the diagnosis rates have been improving in developing countries such as China, India, Japan, Brazil, and other southeast Asian countries.

01 December 2020

READ

Visiongain Publishes RNA Analysis/Transcriptomics Market Report 2020-2030

Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.

30 November 2020

READ

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Categories

Category